The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-S&P, Nasdaq close at new highs as Wall Street rides bull momentum

Mon, 24th Aug 2020 21:20

(For a live blog on the U.S. stock market, click or
type LIVE/ in a news window.)

* Apple closes above $500 per share

* Republican National Convention begins

* Energy, financial sectors lead gains

* Indexes up: Dow 1.35%, S&P 1.00%, Nasdaq 0.60%
(Adds closing prices)

By Stephen Culp

NEW YORK, Aug 24 (Reuters) - The S&P 500 and the Nasdaq
reached new record closing highs on Monday as optimism over
potential medical advances in the war against the coronavirus
pandemic pushed all three major U.S. stock indexes higher.

The benchmark S&P 500 reclaimed its February closing high
last week, confirming a bull market and the fastest recovery
from a bear market trough on record.

The blue-chip Dow, while leading Monday's gains, remains
nearly 4.2% below its all-time high, and down 0.8% year-to-date.
The Nasdaq and the S&P have gained 26.8% and 6.2%, respectively,
since the final closing bell of 2019.

Of note, the Dow Transports index, often considered a
barometer of U.S. economic health, handily outperformed the
broader market.

"There's been a broadening in this rally and the what's
reflected in the transports," said Chuck Carlson, chief
executive officer at Horizon Investment Services in Hammond,
Indiana. "(Higher) volume is accompanying this expanding
breadth, and those are all bullish things."

Markets worldwide were given a boost by new developments in
the global race to battle the coronavirus, including an
announcement from the Food and Drug Administration that it had
given emergency authorization for the use of plasma from
recovered patients as a treatment option.

However, the World Health Organization expressed skepticism
about the treatment due to "low quality" data.

The Trump administration is considering fast-tracking an
experimental COVID-19 vaccine being developed by AstraZeneca Plc
and Oxford University in hopes it could be deployed in
the United States before Americans head to the polls in
November.

"There's an element of that news helping the 'reopening
trade,' which is a euphemism of economically sensitive stocks
performing better," Carlson added.

The four-day Republican national convention got under way on
Monday, with the party making the case for Trump's re-election.

On Capitol Hill, Democrats and Republicans remained at
loggerheads over funding levels and unemployment benefits.

Market participants will pay close attention to U.S. Federal
Reserve Chairman Jerome Powell's remarks on monetary policy at
this week's Kansas City Fed Jackson Hole symposium, which is
being held this year in a virtual format.

The Dow Jones Industrial Average rose 378.13 points,
or 1.35%, to 28,308.46, the S&P 500 gained 34.12 points,
or 1.00%, to 3,431.28 and the Nasdaq Composite added
67.92 points, or 0.6%, to 11,379.72.

Of the 11 major sectors in the S&P 500, all but healthcare
ended the session in the black.

Energy and financials enjoyed the largest
percentage gains.

Ahead of its 4-to-1 share split on Friday, Apple Inc
provided the biggest boost to the S&P 500 and the
Nasdaq, its share price closing above $500 days after becoming
the first public U.S. company to top $2 trillion in market
value. The stock gained 1.2%.

Boeing Co gave the Dow its biggest lift, rising 6.4%.

Advancing issues outnumbered declining ones on the NYSE by a
2.52-to-1 ratio; on Nasdaq, a 1.26-to-1 ratio favored advancers.

The S&P 500 posted 45 new 52-week highs and no new lows; the
Nasdaq Composite recorded 84 new highs and 36 new lows.

Volume on U.S. exchanges was 8.94 billion shares, compared
with the 9.53 billion average over the last 20 trading days.
(Reporting by Stephen Culp; Editing by Cynthia Osterman)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.